Mutational derivatives of PhiC31 integrase with increased efficiency and specificity

Molecular Therapy

Volumn 17, Issue 1, 2009, Pages 112-120

  Keravala, Annahita ^a   Lee, Solomon ^a   Thyagarajan, Bhaskar ^b   Olivares, Eric C ^b   Gabrovsky, Vanessa E ^a   Woodard, Lauren E ^a   Calos, Michele P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Poetic Genetics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 9; INTEGRASE; PHI C 31 INTEGRASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA INTEGRATION; DNA MODIFICATION; ENZYME SPECIFICITY; FEASIBILITY STUDY; FEMALE; GENE ISOLATION; GENE MUTATION; GENE SEQUENCE; GENE THERAPY; GENETIC ENGINEERING; GENETIC RECOMBINATION; GENETIC SCREENING; HELA CELL; HUMAN; HUMAN CELL; LIVER; LONG TERM EXPOSURE; MOUSE; MUTANT; MUTATIONAL ANALYSIS; NONHUMAN; SEQUENCE ANALYSIS; WILD TYPE;

ATTACHMENT SITES, MICROBIOLOGICAL; CELL LINE; HUMANS; INTEGRASES; MUTATION; RECOMBINATION, GENETIC; SUBSTRATE SPECIFICITY;

MAMMALIA;

EID: 58149265300     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2008.241     Document Type: Article

References (46)

1. Kuhstoss, S and Rao, RN (1991). Analysis of the integration function of the Streptomycete bacteriophage C31. J Mol Biol 222: 897-908.
2. Rausch, H and Lehmann, M (1991). Structural analysis of the actinophage C31 attachment site. Nucleic Acids Res 19: 5187-5189.
3. Thorpe, HM and Smith, MC (1998). In vitro site-specific integration of bacteriophage DNA catalyzed by a recombinase of the resolvase/invertase family. Proc Natl Acad Sci USA 95: 5505-5510.
4. Groth, AC, Olivares, EC, Thyagarajan, B and Calos, MP (2000). A phage integrase directs efficient site-specific integration in human cells. Proc Natl Acad Sci USA 97: 5995-6000.
5. Thyagarajan, B, Olivares, EC, Hollis, RP, Ginsburg, DS and Calos, MP (2001). Site-specific genomic integration in mammalian cells mediated by phage C31 integrase. Mol Cell Biol 21: 3926-3934.
6. Chalberg, TW, Portlock, JL, Olivares, EC, Thyagarajan, B, Kirby, PJ, Hillman, RT et al. (2006). Integration specificity of phage C31 integrase in the human genome. J Mol Biol 357: 28-48.
7. Olivares, EC, Hollis, RP, Chalberg, TW, Meuse, L, Kay, MA and Calos, MP (2002). Site-specific genomic integration produces therapeutic factor IX levels in mice. Nat Biotechnol 20: 1124-1128.
8. Held, PK, Olivares, EC, Aguilar, CP, Finegold, M, Calos, MP and Grompe, M (2005). In vivo correction of murine hereditary tyrosinemia type I by C31 integrase-mediated gene delivery. Mol Ther 11: 399-408.
9. Ortiz-Urda, S, Thyagarajan, B, Keene, D, Lin, Q, Fang, M, Calos, MP et al. (2002). Stable nonviral genetic correction of inherited human skin disease. Nat Med 8: 1166-1170.
10. Ortiz-Urda, S, Keene, D, Lin, Q, Calos, MP and Khavari, P (2003). C31 integrase-mediated nonviral genetic correction of junctional epidermolysis bullosa. Hum Gene Ther 14: 923-928.
11. Chalberg, TW, Genise, H L, Vollrath, D and Calos, MP (2005). C31 integrase confers genomic integration and long-term transgene expression in rat retina. Invest Ophthalmol Vis Sci 46: 2140-2146.
12. Keravala, A, Portlock, J, Nash, JA, Vitrant, DG, Robbins, PD and Calos, MP (2006). PhiC31 integrase mediates integration in cultured synovial cells and enhances gene expression in rabbit joints. J Gene Med 8: 1008-1017.
13. Bertoni, C, Jarrahian, S, Wheeler, TM, Li, Y, Olivares, EC, Calos, MP et al. (2006). Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration. Proc Natl Acad Sci USA 103: 419-424.
14. 164 in mouse hindlimb muscle mediated by phage phiC31 integrase after nonviral DNA delivery. Hum Gene Ther 17: 871-876.
15. Quenneville, SP, Chapdelaine, P, Rousseau, J and Tremblay, J (2007). Dystrophin expression in host muscle following transplantation of muscle precursor cells modified with the phiC31 integrase. Gene Ther 14: 514-522.
16. Quenneville, SP, Chapdelaine, P, Rousseau, J, Beaulieu, J, Caron, NJ, Skuk, D et al. (2004). Nucleofection of muscle-derived stem cells and myoblasts with C31 integrase: Stable expression of a full-length-dystrophin fusion gene by human myoblasts. Mol Ther 10: 679-687.
17. Ishikawa, Y, Tanaka, N, Murakami, K, Uchiyama, T, Kumaki, S, Tshuchiya, S et al. (2006). Phage phiC31 integrase-mediated genomic integration of the common cytokine receptor gamma chain in human T-cell lines. J Gene Med 8: 646-653.
18. Thyagarajan, B, Liu, Y, Shin, S, Lakshmipathy, U, Scheyhing, K, Xue, H et al. (2008). Creation of engineered human embryonic stem cell lines using phiC31 integrase. Stem Cells 26: 119-126.
19. Keravala, A, Ormerod, BK, Palmer, T and Calos, MP (2008). Long-term gene expression in phiC31 integrase-modified mouse neural progenitor cells. Neurosci Methods 173: 299-305.
20. Groth, AC, Fish, M, Nusse, R and Calos, MP (2004). Creation of transgenic Drosophila by using the site-specific integrase from phage C31. Genetics 166: 1775-1782.
21. Bateman, JR, Lee, AM and Wu, CT (2006). Site-specific transformation of Drosophila via phiC31 integrase-mediated cassette exchange. Genetics 173: 769-777.
22. Venken, K, He, Y, Hoskins, RA and Bellen, HJ (2006). P[acman]: A BAC transgenic platform for targeted insertion of large DNA fragments in D. melanogaster. Science 314: 1747-1751.
23. Bischof, J, Maeda, RK, Hediger, M, Karch, F and Basler, K (2007). An optimized transgenesis system for Drosophila using germ-line-specific phiC31 integrase. Proc Natl Acad Sci USA 104 3312-3317.
24. Allen, BG and Weeks, DL (2005). Transgenic Xenopus laevis embryos can be generated using phiC31 integrase. Nat Methods 2: 975-979.
25. Nimmo, DD, Alphey, L, Meredith, JM and Eggleston, P (2006). High efficiency site-specific genetic engineering of the mosquito genome. Insect Mol Biol 15: 129-136.
26. Calos, MP (2006). The phiC31integrase system for gene therapy. Curr Gene Ther 6: 633-645.
27. Belteki, G, Gertsenstin, M, Ow, DW and Nagy, A (2003). Site-specific cassette exchange and germline transmission with mouse ES cells expressing the C31 integrase. Nat Biotechnol 21: 321-324.
28. Raymond, CS and Soriano, P (2007). High-efficiency FLP and C31 site-specific recombination in mammalian cells. PLoS ONE 2: e162.
29. Sclimenti, CR, Thyagarajan, B and Calos, MP (2001). Directed evolution of a recombinase for improved genomic integration at a native human sequence. Nucleic Acids Res 29: 5044-5051.
30. Smith, MC and Thorpe, HM (2002). Diversity in the serine recombinases. Mol Microbiol 44: 299-307.
31. Zhang, G, Budker, V and Wolff, JA (1999). High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther 10: 1735-1737.
32. Liu, F, Song, YK and Liu, D (1999). Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther 6 1258-1266.
33. Yant, SR, Park, J, Huang, Y, Mikkelsen, JG and Kay, MA (2004). Mutational analysis of the N-terminal DNA-binding domain of Sleeping Beauty transposase: Critical residues for DNA binding and hyperactivity in mammalian cells. Mol Cell Biol 24: 9239-9247.
34. Zayed, H, Izsvak, Z, Walisko, O and Ivics, Z (2004). Development of hyperactive sleeping beauty transposon vectors by mutational analysis. Mol Ther 9: 292-304.
35. Keravala, A, Liu, D, Lechman, ER, Wolfe, D, Nash, JA, Lampe, DJ et al. (2006). Hyperactive Himar1 transposase mediates transposition in cell culture and enhances gene expression in vivo. Hum Gene Ther 17: 1006-1018.
36. Bushman, F (2002). Targeting retroviral integration? Mol Ther 6 570-571.
37. Tan, W, Dong, Z, Wilkinson, TA, Barbas, CF 3rd and Chow, SA (2006). Human immunodeficiency virus type 1 incorporated with fusion proteins consisting of integrase and the designed polydactyl zinc finger protein E2C can bias integration of viral DNA into a predetermined chromosomal region in human cells. J Virol 80: 1939-1948.
38. Yant, SR, Huang, Y, Akache, B and Kay, MA (2007). Site-directed transposon integration in human cells. Nucleic Acids Res 35: e50.
39. Santiago, Y, Chan, E, Liu, P, Orlando, S, Zhang, L, Urnov, FD et al. (2008). Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases. Proc Natl Acad Sci USA 105: 5809-5814.
40. Hollis, RP, Stoll, SM, Sclimenti, CR, Lin, J, Chen-Tsai, Y and Calos, MP (2003). Phage integrases for the construction and manipulation of transgenic mammals. Reprod Biol and Endocrinol 1: 79-90.
41. Yang, W and Steitz, TA (1995). Crystal-structure of the site-specific recombinase gamma-delta resolvase complexed with a 34 bp cleavage site. Cell 82: 193-207.
42. Yuan, P, Gupta, K and Van Duyne, GD (2008). Tetrameric structure of a serine integrase catalytic domain. Structure 16: 1275-1286.
43. Grindley, ND, Whiteson, KL and Rice, PA (2006). Mechanisms of site-specific recombination. Ann Rev Biochem 75: 567-605.
44. Wang, GP, Ciuffi, A, Leipzig, J, Berry, CC, Bushman, FD (2007). HIV integration site selection: Analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. Genome Res 17: 1186-1194.
45. Miao, CH, Ohashi, K, Patijn, GA, Meuse, L, Ye, X, Thompson, AR et al. (2000). Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro. Mol Ther 1: 522-532.
46. Laird, P, Zijderveld, A, Linders, K, Rudnicki, M, Jaenisch, R and Berns, A (1991). Simplified mammalian DNA isolation procedure. Nucleic Acids Res 19: 4293.